CSEIX
Price
$18.26
Change
-$0.04 (-0.22%)
Updated
Aug 21 closing price
Net Assets
9.87B
RYCRX
Price
$35.19
Change
-$0.04 (-0.11%)
Updated
Aug 21 closing price
Net Assets
4.21M
Interact to see
Advertisement

CSEIX vs RYCRX

CSEIX vs RYCRX Comparison Chart in %
View a ticker or compare two or three
VS
CSEIX vs. RYCRX commentary
Aug 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSEIX is a Hold and RYCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CSEIX has more cash in the bank: 9.87B vs. RYCRX (4.21M). RYCRX pays higher dividends than CSEIX: RYCRX (3.95) vs CSEIX (1.66). CSEIX was incepted earlier than RYCRX: CSEIX (29 years) vs RYCRX (23 years). RYCRX (2.43) is less costly to investors than CSEIX (1.10). RYCRX is a more actively managed with annual turnover of: 1408.00 vs. CSEIX (27.00). CSEIX has a lower initial minimum investment than RYCRX: CSEIX (0) vs RYCRX (2500). CSEIX annual gain was more profitable for investors over the last year : 14.33 vs. RYCRX (11.09). CSEIX return over 5 years is better than : 8.59 vs. RYCRX (2.56).
CSEIXRYCRXCSEIX / RYCRX
Total Expense Ratio1.102.3846%
Annual Report Gross Expense Ratio1.102.4345%
Fund Existence29 years23 years-
Gain YTD15.02411.009136%
Front Load5%N/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets9.87B4.21M234,434%
Annual Yield % from dividends1.663.9542%
Returns for 1 year14.3311.09129%
Returns for 3 years40.8233.21123%
Returns for 5 years8.592.56336%
Returns for 10 years58.0634.71167%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GOIOX39.200.47
+1.21%
JHancock International Growth 1
WENRX65.980.49
+0.75%
Allspring Mid Cap Growth Fund - Cl R6
RYVLX842.175.14
+0.61%
Rydex NASDAQ-100® 2x Strategy A
LVPSX105.960.51
+0.48%
ProFunds Large Cap Value Svc
ARIGX15.920.05
+0.32%
Aristotle Growth Equity I